Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | CPA1 | P15085 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GRN | P28799 | 1/20 | 0.43 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP7 | P09237 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27693745 | 0.80 | MME (0.53) | MMELTA4HGAAACECPA1 | |
| SCHEMBL547805 | 0.78 | SMN1; SMN2 (0.42) | ALDH1A1 | |
| SCHEMBL9831516 | 0.77 | MME (0.50) | MMELTA4HMMP2MMP7MMP9 | |
| SCHEMBL6854264 | 0.77 | MME (0.54) | MMELTA4HACECPA1ACE2 | |
| SCHEMBL9813994 | 0.77 | MME (0.58) | MMELTA4HACECPA1ACE2 | |
| SCHEMBL3863960 | 0.75 | ALDH1A1 (0.49) | ALDH1A1 | |
| SCHEMBL27675065 | 0.74 | MME (0.47) | MMELTA4HALDH1A1MMP2MMP7 | |
| SCHEMBL7434243 | 0.74 | MME (0.47) | MMEGAAALDH1A1MMP2MMP7 | |
| SCHEMBL7275108 | 0.74 | MME (0.47) | MMEALDH1A1 | |
| SCHEMBL30414758 | 0.74 | MME (0.52) | MMELTA4HGAAACECPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1726044-A | Compositions and methods for enhancing mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity | NASTECH PHARM CO (US) | 2006-01-25 | — | — | CN | disclosed |